Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2006 Oct;32(4):786-94.
doi: 10.1093/schbul/sbl011. Epub 2006 Aug 3.

Medication adherence in schizophrenia: exploring patients', carers' and professionals' views

Martijn J Kikkert  1 , Aart H Schene, Maarten W J Koeter, Debbie Robson, Anja Born, Hedda Helm, Michela Nose, Claudia Goss, Graham Thornicroft, Richard J Gray
Affiliations
Randomized Controlled Trial

Medication adherence in schizophrenia: exploring patients', carers' and professionals' views

Martijn J Kikkert et al. Schizophr Bull. 2006 Oct.

Abstract

One of the major clinical problems in the treatment of people with schizophrenia is suboptimal medication adherence. Most research focusing on determinants of nonadherence use quantitative research methods. These studies have some important limitations in exploring the decision-making process of patients concerning medication. In this study we explore factors influencing medication adherence behavior in people with schizophrenia using concept mapping. Concept mapping is a structured qualitative method and was performed in 4 European countries. Participants were 27 patients with schizophrenia, 29 carers, and 28 professionals of patients with schizophrenia. Five clinically relevant themes were identified that affect adherence: medication efficacy, external factors (such as patient support and therapeutic alliance), insight, side effects, and attitudes toward medication. Importance ratings of these factors differed significantly between professionals and carers and patients. Professionals, carers, and patients do not have a shared understanding of which factors are important in patients' medication adherence behavior. Adherence may be positively influenced if professionals focus on the positive aspects of medication, on enhancing insight, and on fostering a positive therapeutic relationship with patients and carers.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Concept map of factors influencing medication adherence for patients with schizophrenia. The map displays the 82 statements as dots, the 10 clusters, and 5 clinical themes; medication efficacy (m), external factors (e), insight (i), side effects (s), and medication attitudes (a). Distance between statements indicates how often they have been sorted together.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Haynes RB, McDonald HP, Garg AX. Interventions for Helping Patients to Follow Prescriptions for Medications. Issue 2. Oxford: Cochrane Library Update Software; 2002. - PubMed
    1. World Health Report. The magnitude of the problem of poor adherence. In: Sabaté E, editor. Adherence to Long Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003. pp. 7–10.
    1. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiat. 2002;63:892–909. - PubMed
    1. Lindstrom E, Bingefors K. Patient compliance with drug therapy in schizophrenia: economic and clinical issues. Pharmacoeconomics. 2000;18:105–124. - PubMed
    1. Oehl M, Hummer M, Fleischhacker WW. Compliance with antipsychotic treatment. Acta Psychiatr Scand. 2000;102:83–86. - PubMed

Publication types

MeSH terms

Substances